000
| 01489nam 2200289za 4500 |
---|
001 | 9.848199 |
---|
003 | CaOODSP |
---|
005 | 20221107153622 |
---|
007 | cr ||||||||||| |
---|
008 | 171201s2018 onca o f000 0 eng d |
---|
020 | |a9780660240954|z9780660240961 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aNR16-188/2017E-PDF |
---|
110 | 2 |aNational Research Council Canada. |
---|
245 | 10|aPreclinical in vivo facility |h[electronic resource]. |
---|
260 | |a[Ottawa] : |bNational Research Council Canada, |c2018. |
---|
300 | |a[2] p. : |bcol. ill. |
---|
500 | |aIssued also in French under title: Installation préclinique in vivo. |
---|
500 | |aCaption title. |
---|
500 | |a"March 2018." |
---|
520 | |a"The Preclinical in vivo Facility leverages the NRC’s expertise in cell and molecular biology, chemistry, nanotechnology, computer and imaging science to evaluate biologics and vaccines in a variety of disease and challenge models. Our expertise and state-of-the-art equipment enables our clients to validate their biologics and vaccine design approaches and obtain a clear picture of the preclinical safety and efficacy of their products"--P. [1]. |
---|
530 | |aIssued also in print format. |
---|
693 | 4|aPharmaceutical biotechnology |
---|
775 | 08|tInstallation préclinique in vivo |w(CaOODSP)9.848201 |
---|
776 | 0#|tPreclinical in vivo facility |w(CaOODSP)9.848200 |
---|
856 | 40|qPDF|s160 KB|uhttps://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-188-2017-eng.pdf |
---|